StonvexLoading…
StonvexStonvexStonvexCore line items from RBRK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $1.32B | $886.54M | $627.89M | $599.82M |
Operating Income | $-345.42M | $-1.13B | $-306.51M | $-261.55M |
Net Income | $-348.83M | $-1.15B | $-354.16M | $-277.75M |
EPS (Diluted) | $-1.78 | $-7.48 | $-5.84 | $-4.66 |
Total Assets | $2.77B | $1.42B | $873.61M | Not available |
Total Liabilities | $3.29B | $1.98B | $1.58B | Not available |
Cash & Equivalents | $380.20M | $186.33M | $130.03M | $140.61M |
Free Cash Flow OCF − CapEx | $253.28M | $31.34M | $-16.85M | $-5.73M |
Shares Outstanding | 196.47M | 154.29M | 60.63M | 59.59M |